{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:13:51Z","timestamp":1789726431143,"version":"4.0.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T00:00:00Z","timestamp":1317686400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The gamma-isoform of the 14-3-3 protein (14-3-3 gamma) is expressed in neurons, and could be a specific marker for neuronal damage. This protein has been reported as a detectable biomarker, especially in the cerebrospinal fluid (CSF) of Creutzfeldt-Jakob disease (CJD) patients by Western blotting (WB) or enzyme-linked immunosorbent assays (ELISAs). Western blotting for 14-3-3 gamma is not sensitive, and the reported data are conflicting among publications. An ELISA specific for 14-3-3 gamma is not available.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>CJD patients (n = 114 sporadic CJD patients, 7 genetic CJD, and 3 iatrogenic CJD) and 99 patients with other neurodegenerative diseases were examined in this study. The CSF samples obtained were analyzed by Western blotting for 14-3-3 gamma, and by ELISA for total tau protein. We evaluated the sensitivity and specificity of the newly developed sandwich ELISA for 14-3-3 gamma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The cut-off value of the 14-3-3 gamma ELISA was &gt; 1, 683 AU\/ml; and sensitivity was 95.2%, with 72.7% specificity. This specificity was the same for the total tau protein ELISA. Seven CJD cases were negative by WB but positive using the 14-3-3 gamma ELISA, indicating that the ELISA is more sensitive. All 21 cases of early stage CJD could be diagnosed using a combination of the 14-3-3\u03b3 ELISA and diffusion weighted MR imaging (DWI-MRI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The 14-3-3 gamma ELISA was more sensitive than conventional WB, and was useful for laboratory diagnosis of CJD, similar to the ELISA for the tau protein. Using DWI-MRI and these ELISA tests on CSF, diagnosis of CJD will be possible even at early stages of the disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2377-11-120","type":"journal-article","created":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T00:27:10Z","timestamp":1317774430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease"],"prefix":"10.1186","volume":"11","author":[{"given":"Yuki","family":"Matsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Shirabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichiro","family":"Atarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Mutsukura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,4]]},"reference":[{"issue":"13","key":"528_CR1","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJM199609263351303","volume":"335","author":"G Hsich","year":"1996","unstructured":"Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG: The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. The New England journal of medicine. 1996, 335 (13): 924-930. 10.1056\/NEJM199609263351303.","journal-title":"The New England journal of medicine"},{"issue":"5","key":"528_CR2","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1212\/WNL.54.5.1095","volume":"54","author":"JP Brandel","year":"2000","unstructured":"Brandel JP, Delasnerie-Laupretre N, Laplanche JL, Hauw JJ, Alperovitch A: Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology. 2000, 54 (5): 1095-1099.","journal-title":"Neurology"},{"issue":"11","key":"528_CR3","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/labinvest.2009.68","volume":"90","author":"K Satoh","year":"2010","unstructured":"Satoh K, Tobiume M, Matsui Y, Mutsukura K, Nishida N, Shiga Y, Eguhchi K, Shirabe S, Sata T: Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease. Laboratory investigation; a journal of technical methods and pathology. 2010, 90 (11): 1637-1644.3. 10.1038\/labinvest.2009.68.","journal-title":"Laboratory investigation; a journal of technical methods and pathology"},{"issue":"3","key":"528_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/1531-8249(200009)48:3<395::AID-ANA18>3.0.CO;2-A","volume":"48","author":"K Kenney","year":"2000","unstructured":"Kenney K, Brechtel C, Takahashi H, Kurohara K, Anderson P, Gibbs CJ: An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Annals of neurology. 2000, 48 (3): 395-398. 10.1002\/1531-8249(200009)48:3<395::AID-ANA18>3.0.CO;2-A.","journal-title":"Annals of neurology"},{"issue":"11","key":"528_CR5","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.neurobiolaging.2008.01.007","volume":"30","author":"K Gmitterova","year":"2009","unstructured":"Gmitterova K, Heinemann U, Bodemer M, Krasnianski A, Meissner B, Kretzschmar HA, Zerr I: 14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes. Neurobiology of aging. 2009, 30 (11): 1842-1850. 10.1016\/j.neurobiolaging.2008.01.007.","journal-title":"Neurobiology of aging"},{"issue":"3","key":"528_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000107082","volume":"24","author":"K Satoh","year":"2007","unstructured":"Satoh K, Shirabe S, Tsujino A, Eguchi H, Motomura M, Honda H, Tomita I, Satoh A, Tsujihata M, Matsuo H, et al: Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease. Dementia and geriatric cognitive disorders. 2007, 24 (3): 207-212. 10.1159\/000107082.","journal-title":"Dementia and geriatric cognitive disorders"},{"issue":"2","key":"528_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamanaka H, Shirabe S, et al: Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nature medicine. 2011, 17 (2): 175-178. 10.1038\/nm.2294.","journal-title":"Nature medicine"},{"issue":"11","key":"528_CR8","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/jnnp.2009.197962","volume":"81","author":"G Chohan","year":"2010","unstructured":"Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D, Will RG, Knight RS, Green AJ: The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. Journal of neurology, neurosurgery and psychiatry. 2010, 81 (11): 1243-1248. 10.1136\/jnnp.2009.197962.","journal-title":"Journal of neurology, neurosurgery and psychiatry"},{"issue":"4","key":"528_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","volume":"67","author":"P Sanchez-Juan","year":"2006","unstructured":"Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Saanchez-Valle R, Mitrovaa E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, et al: CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2006, 67 (4): 637-643. 10.1212\/01.wnl.0000230159.67128.00.","journal-title":"Neurology"},{"issue":"1","key":"528_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neulet.2009.02.067","volume":"455","author":"C Pennington","year":"2009","unstructured":"Pennington C, Chohan G, Mackenzie J, Andrews M, Will R, Knight R, Green A: The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease. Neuroscience letters. 2009, 455 (1): 56-59. 10.1016\/j.neulet.2009.02.067.","journal-title":"Neuroscience letters"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-11-120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-11-120\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-11-120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-11-120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:11:52Z","timestamp":1630516312000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-11-120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,4]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["528"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-11-120","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,4]]},"assertion":[{"value":"22 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"120"}}